SHE:300584 Revenue

Nanjing Hicin Pharmaceutical had revenue of 142.65M CNY in the quarter ending March 31, 2025, with 36.43% growth. This brings the company's revenue in the last twelve months to 542.45M, up 7.37% year-over-year. In the year 2024, Nanjing Hicin Pharmaceutical had annual revenue of 504.36M, down -2.60%.

Revenue (ttm)

542.45M

Revenue Growth

+7.37%

P/S Ratio

6.08

Revenue / Employee

980.92K

Employees

553

Market Cap

3.30B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	504.36M	-13.47M	-2.60%
Dec 31, 2023	517.83M	-8.63M	-1.64%
Jan 1, 2023	526.47M	-51.85M	-8.97%
Jan 1, 2022	578.32M	-127.98M	-18.12%
Dec 31, 2020	706.30M	-218.24M	-23.61%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	29.19B
Shenzhen Mindray Bio-Medical Electronics	35.59B
WuXi AppTec	39.59B
Zhangzhou Pientzehuang Pharmaceutical.,	10.76B
Aier Eye Hospital Group	21.81B
Shanghai United Imaging Healthcare	10.43B
Sichuan Biokin Pharmaceutical	5.82B
Yunnan Baiyao Group Co.,Ltd	40.10B

Revenue Rankings